Trial exclusion patterns Phase 2 and Phase 3 retatrutide trials commonly excluded participants with a history of pancreatitis, medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2 (MEN 2), severe gastroparesis, recent major cardiovascular events, severe kidney impairment, type 1 diabetes (in the obesity studies), and pregnancy or breastfeeding
Mistake 4: Skipping meals entirely
If your BMI is just under the threshold, the addition of HRT for documented hormonal deficiency may support your case for GLP-1 prescription
Jung S, Whiteaker JR, Zhao L, Yoo HW, Paulovich AG, Hahn SH
Their combined use in research demonstrates cytoskeletal and angiogenic synergy ideal for complex tissue restoration